Search Results - "Hayes, Gregory M"

Refine Results
  1. 1

    Antitumor activity of an anti‐CD98 antibody by Hayes, Gregory M., Chinn, Lawrence, Cantor, Joseph M., Cairns, Belinda, Levashova, Zoia, Tran, Hoang, Velilla, Timothy, Duey, Dana, Lippincott, John, Zachwieja, Joseph, Ginsberg, Mark H., H. van der Horst, Edward

    Published in International journal of cancer (01-08-2015)
    “…CD98 is expressed on several tissue types and specifically upregulated on fast‐cycling cells undergoing clonal expansion. Various solid (e.g., nonsmall cell…”
    Get full text
    Journal Article
  2. 2

    The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy by Long, Brian R., Sandza, Krystal, Holcomb, Jennifer, Crockett, Lucy, Hayes, Gregory M., Arens, Jeremy, Fonck, Carlos, Tsuruda, Laurie S., Schweighardt, Becky, O’Neill, Charles A., Zoog, Stephen, Vettermann, Christian

    “…Adeno-associated virus (AAV)-based vectors are widely used for gene therapy, but the effect of pre-existing antibodies resulting from exposure to wild-type AAV…”
    Get full text
    Journal Article
  3. 3

    Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma by HAYES, Gregory M, CARRIGAN, Patricia E, BECK, Alison M, MILLER, Laurence J

    Published in Cancer research (Chicago, Ill.) (01-04-2006)
    “…Aberrant patterns of pre-mRNA splicing have been established for many human malignancies, yet the mechanisms responsible for these tumor-specific changes…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas by HAYES, Gregory M, CARRIGAN, Patricia E, MILLER, Laurence J

    Published in Cancer research (Chicago, Ill.) (01-03-2007)
    “…Aberrant patterns of pre-mRNA processing are typical of human malignancies, yet the mechanisms responsible for these changes remain undefined. We have recently…”
    Get full text
    Journal Article
  7. 7

    Measurement of cell proliferation by heavy water labeling by Hellerstein, Marc K, Busch, Robert, Neese, Richard A, Awada, Mohamad, Hayes, Gregory M

    Published in Nature protocols (01-11-2007)
    “…DNA replication occurs almost exclusively during S-phase of the cell cycle and represents a simple biochemical metric of cell division. Previous methods for…”
    Get full text
    Journal Article
  8. 8

    Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection by Geris, Jennifer M., Stancari, Arianna L., Meirhaeghe, Madeline R., Gautam, Sakhi, Cayatte, Corinne, Schmeling, David O., Okour, Malek F., Brundage, Richard C., Hayes, Gregory M., Balfour, Henry H.

    Published in Journal of clinical virology (01-10-2022)
    “…•More rapid antibody responses in college freshmen who contracted a primary EBV infection.•during prospective surveillance correlated with a lower severity of…”
    Get full text
    Journal Article
  9. 9

    Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo by Servat, Esteban, Ro, Bodrey W, Cayatte, Corinne, Gemmell, Lorraine, Barton, Chris, Rao, Eileen, Lin, Rui, Zuo, Fengrong, Woo, Jennifer C, Hayes, Gregory M

    Published in Vaccine (27-11-2015)
    “…Highlights • Identification of critical quality attributes for EBV gp350 vaccine development. • Requirement of 72A1 epitope on recombinant gp350 for binding to…”
    Get full text
    Journal Article
  10. 10

    Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV by Bu, Wei, Hayes, Gregory M, Liu, Hui, Gemmell, Lorraine, Schmeling, David O, Radecki, Pierce, Aguilar, Fiona, Burbelo, Peter D, Woo, Jennifer, Balfour, Jr, Henry H, Cohen, Jeffrey I

    Published in Clinical and vaccine immunology (01-04-2016)
    “…Prospective studies of antibodies to multiple Epstein-Barr virus (EBV) proteins and EBV neutralizing antibodies in the same individuals before, during, and…”
    Get full text
    Journal Article
  11. 11

    CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma by Hayes, Gregory M, Cairns, Belinda, Levashova, Zoia, Chinn, Lawrence, Perez, Myra, Theunissen, Jan-Willem, Liao-Chan, Sindy, Bermudez, Abel, Flory, Mark R, Schweighofer, Karl J, H van der Horst, Edward

    Published in American journal of translational research (01-01-2015)
    “…Soft tissue sarcoma (STS) is a heterogenous tumor arising from the embryonic mesoderm represented by approximately 50 histological subtypes. Effective…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Identification of Sequence Motifs Responsible for the Adhesive Interaction between Exon v10-containing CD44 Isoforms by Hayes, Gregory M., Chiu, Roland, Carpenito, Carmine, Dougherty, Shona T., Dougherty, Graeme J.

    Published in The Journal of biological chemistry (27-12-2002)
    “…Previous studies have demonstrated that CD44 isoforms containing the alternatively spliced exon v10 promote cell-cell adhesion via a mechanism that involves…”
    Get full text
    Journal Article
  14. 14

    Measurement of very low rates of cell proliferation by heavy water labeling of DNA and gas chromatography/pyrolysis/isotope ratio-mass spectrometric analysis by Hellerstein, Marc K, Voogt, Jason N, Awada, Mohamad, Murphy, Elizabeth J, Hayes, Gregory M, Busch, Robert

    Published in Nature protocols (01-11-2007)
    “…DNA replication during S-phase represents a biochemical metric of cell division. We present here a protocol for measuring very low rates of cell proliferation,…”
    Get full text
    Journal Article
  15. 15

    Secretin receptors in the human liver: Expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma by Körner, Meike, Hayes, Gregory M., Rehmann, Ruth, Zimmermann, Arthur, Scholz, Arne, Wiedenmann, Bertram, Miller, Laurence J., Reubi, Jean Claude

    Published in Journal of hepatology (01-12-2006)
    “…Gut hormone receptors are over-expressed in human cancer and allow receptor-targeted tumor imaging and therapy. A novel promising receptor for these purposes…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Identification and Characterization of CD44RC, a Novel Alternatively Spliced Soluble CD44 Isoform that can Potentiate the Hyaluronan Binding Activity of Cell Surface CD44 by Chiu, Roland K., Carpenito, Carmine, Dougherty, Shona T., Hayes, Gregory M., Dougherty, Graeme J.

    Published in Neoplasia (New York, N.Y.) (01-11-1999)
    “…Soluble CD44 proteins generated by proteolytic cleavage or aberrant intron retention have been shown to antagonize the ligand binding activity of the…”
    Get full text
    Journal Article
  18. 18

    A Novel Secretin Receptor Splice Variant Potentially Useful for Early Diagnosis of Pancreatic Carcinoma by Hayes, Gregory M, Carrigan, Patricia E, Dong, Maoqing, Reubi, Jean–Claude, Miller, Laurence J

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2007)
    “…Background & Aims: Pancreatic and bile duct carcinomas represent highly aggressive malignancies that evolve from secretin receptor-rich ductular cells. With…”
    Get full text
    Journal Article
  19. 19

    Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue by Körner, Meike U, Hayes, Gregory M, Carrigan, Patricia E, Rehmann, Ruth, Miller, Laurence J, Reubi, Jean C

    Published in Modern pathology (01-04-2008)
    “…Gastrointestinal peptide hormone receptors, like somatostatin receptors, are often overexpressed in human cancer, allowing receptor-targeted tumor imaging and…”
    Get full text
    Journal Article
  20. 20

    Secretin Receptors in Normal and Diseased Human Pancreas: Marked Reduction of Receptor Binding in Ductal Neoplasia by Korner, Meike, Hayes, Gregory M, Rehmann, Ruth, Zimmermann, Arthur, Friess, Helmut, Miller, Laurence J, Reubi, Jean Claude

    Published in The American journal of pathology (01-10-2005)
    “…Receptors for gut hormones, which are often overexpressed in cancer, are clinically relevant for receptor-targeted tumor imaging and therapy. Because the…”
    Get full text
    Journal Article